AF
CAPR icon

Allworth Financial’s Capricor Therapeutics CAPR Stock Holding History

Allworth Financial’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4K Sell
1,095
-972
-47% -$29.5K ﹤0.01% 2972
2026
Q1 		$62.8K Sell
2,067
-1,262
-38% -$33.6K ﹤0.01% 2154
2025
Q4 		$96.1K Buy
3,329
+3,264
+5,022% +$42.6K ﹤0.01% 1784
2025
Q3 		$469 Hold
65
– – ﹤0.01% 4449
2025
Q2 		$646 Buy
+65
New +$687 ﹤0.01% 4070

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Allworth Financial's CAPR Position: Q2 2026 in Review

Allworth Financial reduced its Capricor Therapeutics (CAPR) stake by 47% in Q2 2026, selling an estimated $29.5K and leaving 1,095 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2972.

Allworth Financial first reported a position in CAPR in Q2 2025 and has held it in 5 quarters since. The position peaked at $96.1K in Q4 2025. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Allworth Financial held 1,095 shares of Capricor Therapeutics worth $26.4K as of Q2 2026.
  • Allworth Financial sold 972 Capricor Therapeutics shares in Q2 2026, an estimated $29.5K.
  • Capricor Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2972 holding.
  • Allworth Financial first reported a position in Capricor Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Allworth Financial's Capricor Therapeutics position peaked at $96.1K in Q4 2025.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.